comparemela.com

Latest Breaking News On - Child level menu hover - Page 3 : comparemela.com

FDA declines to grant approval for Gilead Sciences HIV treatment

The US Food and Drug Administration (FDA) has declined to grant approval for Gilead Sciences’ investigational therapy lenacapavir for HIV.

Menu hoverSubchild level menu hoverChild level menu hoverEnd third levelBend articleEnd timeline

ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva

ViiV Healthcare has secured the US FDA approval for the expanded labelling of Cabenuva (cabotegravir, rilpivirine) to treat HIV-1 in adults.

Menu hoverSubchild level menu hoverChild level menu hoverEnd third levelBend articleEnd timeline

Neogene Therapeutics signs global license agreement with NCI

Biotechnology firm Neogene Therapeutics has signed an exclusive, global license agreement with the National Cancer Institute (NCI) for a portfolio of T cell receptor (TCRs) targeting KRAS and TP53 mutations for the treatment of patients suffering with cancer.

Carsten linnemannArek sochaSteven rosenbergNational cancer instituteNational institutes of healthNeogene therapeuticsNational institutesMenu hoverSubchild level menu hoverChild level menu hover

AbbVie seeks approval for upadacitinib to treat nr-axSpA

Abbvie has submitted applications to the US FDA and the EMA to obtain approvals for upadacitinib (RINVOQ) to treat nr-axSpA.

Menu hoverSubchild level menu hoverChild level menu hoverEnd third levelBend articleEnd timeline

Drug Delivery Archives - Pharmaceutical Business review

Drug Delivery Archives - Pharmaceutical Business review
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Menu hoverSubchild level menu hoverChild level menu hoverEnd third level

vimarsana © 2020. All Rights Reserved.